Back to results
US 11,078,165 B2Granted
Compounds for treating tuberculosis
AssigneesNanyang Technological University, National University of Singapore
InventorsGerhard Grüber, Roderick Wayland Bates, Adam Hotra, Thomas Dick, Kevin Pethe
Life of this patent
Estimating the term…
Abstract
The present invention relates to pyrimidine compounds and compositions for treating tuberculosis. These compounds may be used to target the F1 domain of F-ATP synthase and may be used with bedaquiline or 6-chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide (Q203) or a combination thereof.
Claims10
A composition comprising a compound having a structure represented by the following formula:
- wherein R1 and R1a are independently H, halogen, C1-C4 alkyl, C1-C4 alkoxy, OH;
- R2═H, C1-C4 alkyl, C1-C4 alkyl alcohol, C1-C4 alkoxy, —CH2COOEt;
- R3═H, C1-C4 alkyl;
- R4═H, halogen, C1-C4 alkyl, C1-C4 alkoxy;
- X, Y and Z are independently C or N, or a pharmaceutically acceptable salt thereof;
- and
- bedaquiline or
- 6-chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide (Q203), or
- a combination thereof.
6 more elements
Dependencies are inferred from the claim text.